S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.84 (-0.85%)
MSFT   420.46 (-0.23%)
META   488.09 (-1.17%)
GOOGL   151.01 (+0.09%)
AMZN   180.32 (+0.27%)
TSLA   176.77 (-1.70%)
NVDA   904.78 (+0.25%)
NIO   4.53 (-3.00%)
AMD   180.78 (+0.66%)
BABA   72.49 (+1.26%)
T   17.64 (+0.51%)
F   13.21 (+1.15%)
MU   117.96 (-0.99%)
CGC   8.34 (-12.67%)
GE   174.78 (-2.96%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.97 (+0.68%)
PYPL   67.18 (+0.92%)
XOM   116.16 (+1.04%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.84 (-0.85%)
MSFT   420.46 (-0.23%)
META   488.09 (-1.17%)
GOOGL   151.01 (+0.09%)
AMZN   180.32 (+0.27%)
TSLA   176.77 (-1.70%)
NVDA   904.78 (+0.25%)
NIO   4.53 (-3.00%)
AMD   180.78 (+0.66%)
BABA   72.49 (+1.26%)
T   17.64 (+0.51%)
F   13.21 (+1.15%)
MU   117.96 (-0.99%)
CGC   8.34 (-12.67%)
GE   174.78 (-2.96%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.97 (+0.68%)
PYPL   67.18 (+0.92%)
XOM   116.16 (+1.04%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.84 (-0.85%)
MSFT   420.46 (-0.23%)
META   488.09 (-1.17%)
GOOGL   151.01 (+0.09%)
AMZN   180.32 (+0.27%)
TSLA   176.77 (-1.70%)
NVDA   904.78 (+0.25%)
NIO   4.53 (-3.00%)
AMD   180.78 (+0.66%)
BABA   72.49 (+1.26%)
T   17.64 (+0.51%)
F   13.21 (+1.15%)
MU   117.96 (-0.99%)
CGC   8.34 (-12.67%)
GE   174.78 (-2.96%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.97 (+0.68%)
PYPL   67.18 (+0.92%)
XOM   116.16 (+1.04%)
S&P 500   5,252.74 (+0.08%)
DOW   39,774.15 (+0.04%)
QQQ   444.20 (-0.14%)
AAPL   171.84 (-0.85%)
MSFT   420.46 (-0.23%)
META   488.09 (-1.17%)
GOOGL   151.01 (+0.09%)
AMZN   180.32 (+0.27%)
TSLA   176.77 (-1.70%)
NVDA   904.78 (+0.25%)
NIO   4.53 (-3.00%)
AMD   180.78 (+0.66%)
BABA   72.49 (+1.26%)
T   17.64 (+0.51%)
F   13.21 (+1.15%)
MU   117.96 (-0.99%)
CGC   8.34 (-12.67%)
GE   174.78 (-2.96%)
DIS   122.50 (+1.26%)
AMC   3.66 (-15.67%)
PFE   27.97 (+0.68%)
PYPL   67.18 (+0.92%)
XOM   116.16 (+1.04%)
NASDAQ:GHSI

Guardion Health Sciences (GHSI) Stock Price, News & Analysis

$9.01
-0.01 (-0.11%)
(As of 02:21 PM ET)
Today's Range
$8.95
$9.01
50-Day Range
$5.15
$9.09
52-Week Range
$4.99
$10.75
Volume
2,720 shs
Average Volume
227,436 shs
Market Capitalization
$11.53 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
GHSI stock logo

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported nutrition, medical foods, and dietary supplements in North America and Europe, and Internationally. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

GHSI Stock Price History

GHSI Stock News Headlines

Guardion Health Sciences (NASDAQ:GHSI) Stock Price Down 0.9%
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Grab Your Free Bitcoin Today!
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Why Is Guardion Health (GHSI) Stock Up 66% Today?
GHSI - Guardion Health Sciences, Inc.
See More Headlines
Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/12/2019
Today
3/28/2024
Next Earnings (Estimated)
4/15/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GHSI
Employees
12
Year Founded
2009

Profitability

Net Income
$-14,920,000.00
Net Margins
-105.66%
Pretax Margin
-105.66%

Debt

Sales & Book Value

Annual Sales
$11.05 million
Cash Flow
$5.24 per share
Book Value
$6.43 per share

Miscellaneous

Free Float
1,258,000
Market Cap
$11.53 million
Optionable
Not Optionable
Beta
0.87

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

Key Executives

  • Mr. Robert Neal Weingarten (Age 72)
    Independent Chairman & Secretary
    Comp: $79k
  • Mr. Craig J. Sheehan (Age 53)
    Chief Commercial Officer
    Comp: $256.88k
  • Ms. Janet Hall (Age 65)
    President & CEO
  • Ms. Katie Cox (Age 54)
    Chief Accounting Officer

GHSI Stock Analysis - Frequently Asked Questions

Should I buy or sell Guardion Health Sciences stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Guardion Health Sciences in the last twelve months. There are currently 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" GHSI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GHSI, but not buy additional shares or sell existing shares.
View GHSI analyst ratings
or view top-rated stocks.

How have GHSI shares performed in 2024?

Guardion Health Sciences' stock was trading at $5.34 at the start of the year. Since then, GHSI stock has increased by 68.7% and is now trading at $9.01.
View the best growth stocks for 2024 here
.

When is Guardion Health Sciences' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, April 15th 2024.
View our GHSI earnings forecast
.

How were Guardion Health Sciences' earnings last quarter?

Guardion Health Sciences, Inc. (NASDAQ:GHSI) released its quarterly earnings data on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative net margin of 105.66% and a negative trailing twelve-month return on equity of 162.33%.

When did Guardion Health Sciences' stock split?

Guardion Health Sciences's stock reverse split on Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of Guardion Health Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Guardion Health Sciences investors own include iBio (IBIO), Biocept (BIOC), Onconova Therapeutics (ONTX), Heat Biologics (HTBX), VBI Vaccines (VBIV), Inovio Pharmaceuticals (INO), Ocugen (OCGN), Tonix Pharmaceuticals (TNXP), Co-Diagnostics (CODX) and FuelCell Energy (FCEL).

When did Guardion Health Sciences IPO?

Guardion Health Sciences (GHSI) raised $6 million in an initial public offering (IPO) on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

How do I buy shares of Guardion Health Sciences?

Shares of GHSI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:GHSI) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners